This bill prohibits requiring or asking pregnant women about their COVID-19 vaccination status or demanding proof of vaccination for any purpose. It directly affects pregnant women in New Jersey by making it unlawful for employers, schools, healthcare providers, businesses, and others to discriminate against them based on not being vaccinated or refusing to disclose vaccination status. Key provisions ban such requirements across 15 areas, including employment, education, healthcare access, and public accommodations. Violators face $25,000 civil penalties plus attorney fees in court. The bill takes effect immediately upon enactment.
This bill excludes the first $5,000 earned annually as a community outreach worker in health promotion or disease prevention programs from income calculations for New Jersey's Medicaid (NJ FamilyCare), Work First New Jersey (WFNJ), and SNAP programs. It directly affects low-income individuals working temporary, hourly or stipend-based roles with non-profits, health systems, or local health departments - where they connect communities to health services. The key provision ensures this modest income isn’t counted toward eligibility thresholds, preventing beneficiaries from losing assistance due to small earnings. The bill defines "health promotion" as programs empowering healthy behaviors and "disease prevention" as reducing health risks, applying to all three state assistance programs. It requires state agencies to update eligibility rules to implement this change.
This bill changes how vaccines must be administered in New Jersey by requiring healthcare providers to give patients or parents/guardians 48 hours' notice before vaccination. Providers must provide the vaccine manufacturer's insert, information about the federal Vaccine Adverse Event Reporting System (VAERS), and details on opting out - including risks of disease and potential school access restrictions without medical or religious exemptions. Written consent is mandatory before administration, and providers cannot deny care or transfer patients solely due to vaccine refusal. The bill also prohibits using standing orders for vaccines except during declared public health emergencies. It directly affects all patients receiving vaccines, including minors whose parents/guardians must consent.
This bill authorizes New Jersey's Department of Health (DOH) to seek participation in the World Health Organization's Global Outbreak Alert and Response Network (GOARN), a global network for disease outbreak coordination. It directly affects the DOH and New Jersey's public health response system by enabling collaboration on outbreak detection, information-sharing, and emergency preparedness. Key provisions allow the DOH to communicate with GOARN, submit applications, designate contact points, and participate in trainings without creating new legal obligations or requiring additional funding beyond existing appropriations. The bill specifically clarifies it does not establish New Jersey's membership in the WHO or override federal law.
This bill requires New Jersey's Department of Health (DOH) to form formal partnerships with businesses, community groups, healthcare facilities, universities, and other stakeholders to strengthen emergency responses during public health crises. It directs the DOH to identify critical resources and at-risk populations, then develop collaborative response plans, joint training exercises, and systems for sharing partnership data. The law mandates these partnerships to improve the state's ability to coordinate rapid, effective crisis management across multiple sectors. It directly affects the DOH, its partner organizations, and communities most vulnerable during emergencies like pandemics or natural disasters. The bill takes effect immediately upon enactment.
New Jersey's Assembly Bill A4314 establishes free post-COVID-19 health clinics for individuals previously diagnosed with the virus, providing physical and mental health evaluations, therapy, and related services at no cost. It mandates the state health department to create public awareness campaigns about long-term health effects, distribute educational materials in healthcare facilities, and train medical professionals on recognizing and addressing these effects. A new task force will specifically study how long-term health impacts disproportionately affect racial and ethnic minorities in the state. The bill expires one year after the end of New Jersey's official public health emergency for COVID-19.
New Jersey's Bill A1155 establishes a statewide Parkinson's disease registry to track the incidence and prevalence of Parkinson's disease and related conditions (Parkinsonisms) across the state. Health care providers must report diagnosed cases to the registry, including diagnostic details, treatment, and survival data, while allowing patients to opt out in writing. The registry collects only necessary health information, removes personal identifiers through coding, and strictly protects confidentiality - preventing disclosure in legal proceedings or for unauthorized uses. This data will support research, public health planning, and potentially improve care for those affected, with all reporting requirements applying to cases diagnosed both before and after the bill's effective date.
This New Jersey bill (A3944) creates new performance standards for nursing homes, directly affecting facilities that receive federal one-star ratings or fail to meet metrics in three key areas: resident physical health (e.g., bedsores, falls), mental well-being (e.g., medication use, depression), and operational factors (e.g., staff turnover, vaccination rates). It establishes a tiered response system: a warning for first failures, sanctions like restricting Medicaid admissions for repeated failures, and severe penalties including removing Medicaid residents or suspending payments for persistent underperformance. Nursing homes failing standards in three of four consecutive quarters must submit a 18-month improvement plan for state review. The bill aims to strengthen accountability for nursing home quality without specifying expected outcomes.
This bill requires health care professionals (such as doctors, midwives, and nurse practitioners) providing prenatal care to assess pregnant people for lead exposure risks and conduct blood lead screening when indicated. If a pregnant person has an elevated blood lead level, the professional must notify them in writing, explain the health risks of lead poisoning in plain language, and ensure children or household members under six are screened. The bill allows for written patient refusal of screening or if another provider has already completed the test. Laboratory results must be reported to health departments within five business days, with all data kept confidential and anonymized statistics used for public health purposes.
The "HOPE Initiative Act" (A464) requires New Jersey to establish a statewide public awareness campaign to combat the heroin and opioid epidemic. It mandates the Division of Mental Health and Addiction Services to develop a multicultural campaign ("HOPE Initiative") using all media channels to educate diverse audiences - including at-risk individuals, families, medical professionals, first responders, and employers - on addiction pathways, warning signs, treatment options, naloxone use, and prevention strategies. Key provisions include debunking myths about addiction, highlighting treatment benefits, promoting naloxone access, and addressing prescription opioid misuse. The campaign must use culturally appropriate messaging in multiple languages and leverage public-private partnerships for wider reach. This is a procedural bill focused on education, not regulatory changes.
